Tufts OpenCourseware
Search
PREV : Inflammatory Bowel Disease: Treatment NEXT : Dose Response to Mesalamine in Active Ulcerative Colitis
Author: Laurence Scott Bailen, M.D.
Location of Oral Mesalamine Release